CM Management’s Cytosorbents Corp CTSO Stock Holding History

CM Management’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$552K	Hold	1,476,500	–	–	0.35%	65
2026 Q1	$836K	Hold	1,476,500	–	–	0.7%	52
2025 Q4	$944K	Buy	1,476,500 +188,372	+15%	+$145K	0.8%	46
2025 Q3	$1.2M	Buy	1,288,128 +38,128	+3%	+$37.6K	1%	39
2025 Q2	$1.6M	Buy	1,250,000 +295,924	+31%	+$297K	1.46%	28
2025 Q1	$954K	Buy	954,076 +254,076	+36%	+$268K	0.96%	38
2024 Q4	$637K	Sell	700,000 -100,000	-13%	-$98.1K	0.57%	48
2024 Q3	$1.2M	Sell	800,000 -50,000	-6%	-$54.8K	0.96%	41
2024 Q2	$598K	Buy	850,000 +25,000	+3%	+$21.7K	0.55%	50
2024 Q1	$784K	Buy	825,000 +410,000	+99%	+$399K	0.66%	48
2023 Q4	$461K	Sell	415,000 -35,000	-8%	-$52K	0.37%	59
2023 Q3	$846K	Hold	450,000	–	–	0.9%	38
2023 Q2	$1.62M	Hold	450,000	–	–	1.58%	20
2023 Q1	$1.52M	Sell	450,000 -25,000	-5%	-$75K	1.8%	17
2022 Q4	$736K	Sell	475,000 -200,000	-30%	-$297K	0.88%	36
2022 Q3	$918K	Buy	675,000 +75,000	+13%	+$146K	1.02%	36
2022 Q2	$1.31M	Buy	600,000 +250,000	+71%	+$574K	1.4%	28
2022 Q1	$1.12M	Buy	350,000 +50,000	+17%	+$179K	0.94%	38
2021 Q4	$1.26M	Buy	300,000 +125,000	+71%	+$701K	0.95%	33
2021 Q3	$1.42M	Buy	175,000 +25,000	+17%	+$203K	1.06%	32
2021 Q2	$1.13M	Buy	150,000 +30,000	+25%	+$253K	0.82%	46
2021 Q1	$1.04M	Buy	+120,000	New	+$1.14M	0.77%	55

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

CM Management's CTSO Position: Q2 2026 in Review

CM Management held its Cytosorbents Corp (CTSO) position steady in Q2 2026 at 1,476,500 shares worth $552K. The position accounts for 0.35% of the portfolio, ranked #65.

CM Management first reported a position in CTSO in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.62M in Q2 2023. 42 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

CM Management held 1,476,500 shares of Cytosorbents Corp worth $552K as of Q2 2026.
CM Management left its Cytosorbents Corp share count unchanged in Q2 2026.
Cytosorbents Corp made up 0.35% of CM Management's portfolio in Q2 2026, its #65 holding.
CM Management first reported a position in Cytosorbents Corp in Q1 2021 and has held it in 22 quarters since.
CM Management's Cytosorbents Corp position peaked at $1.62M in Q2 2023.
42 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.